Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.
F.D.A. Faces Upset Over Denials of New Drugs
Date:
More like thisRelated
To Play a Man With Tourette’s, He Swapped the Script for Real Life
Robert Aramayo immersed himself in John Davidson’s life to...
Book bans and attempted bans remain at record highs, with ‘Sold’ topping the list
The American Library Association says book bans and attempted...
The President Is Coming to the White House Correspondent’s Dinner
A president who relishes attacking the news media is...